Canada · 
Who invested in Zucara Therapeutics?
Zucara Therapeutics's investors include Y Combinator, Perceptive Advisors, Sanofi and National Research Council of Canada Industrial Research Assistance Program.
Canada · Series B startup
Who invested in Zucara Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $5.0MMay 2025
- Investors
- 4
The rounds
- May 2025Series B$5.0M
Y Combinator
Perceptive Advisors
Sanofi- National Research Council of Canada Industrial Research Assistance Program
Source recordedSEC filing: $5.0M sold, first sale Feb 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Zucara Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Zucara Therapeutics
How much has Zucara Therapeutics raised?
Zucara Therapeutics has raised $5.0M across 1 round since 2025.
When did Zucara Therapeutics last raise?
Zucara Therapeutics's most recent round was a Series B of $5.0M in May 2025.
What was Zucara Therapeutics's biggest round?
Its most recent round, $5.0M in May 2025, is also its largest on record.
Who backed Zucara Therapeutics first?
Zucara Therapeutics's first round on record, in May 2025, was backed by Y Combinator, Perceptive Advisors and Sanofi and 1 others.
What stage is Zucara Therapeutics at?
Zucara Therapeutics's latest named round is a Series B, in May 2025.
Where is Zucara Therapeutics based?
Zucara Therapeutics is based in Canada.
Companies like Zucara Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.